KRYS+130.31%14.3%
NTLA+22.05%14.3%
QURE+208.09%14.3%
RARE-13.26%14.3%
SLNO0.00%14.3%
SRPT-7.07%14.3%
SRRK+59.20%14.3%
As of Aug 24, 2026, 4:53 AM ET
Rare Diseases '25: Gene Therapy & Genetic Med Constituents
Intellia Therapeutics, Inc.NTLA | 14.3% | 3.22% | 6.82% | 19.66% | 20.22% | 42.83% | -6.82% | 75.89% | -45.66% | -91.88% | 22.05% | $1.79B |
Krystal Biotech, Inc.KRYS | 14.3% | 2.84% | 5.97% | 3.40% | 1.60% | 40.58% | 25.74% | 91.48% | 71.93% | 515.49% | 130.31% | $10.22B |
Sarepta Therapeutics, Inc.SRPT | 14.3% | -2.24% | 3.13% | 19.83% | 26.45% | -12.69% | 12.11% | -69.92% | -86.63% | -74.37% | -7.07% | $1.98B |
Scholar Rock Holding CorporationSRRK | 14.3% | 2.26% | 8.51% | 18.52% | 19.46% | 28.26% | 27.63% | 73.63% | 509.49% | 36.77% | 59.20% | $6.77B |
Soleno Therapeutics, Inc.SLNO | 14.3% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | $1.06B |
Ultragenyx Pharmaceutical Inc.RARE | 14.3% | 2.01% | -4.19% | -3.98% | 3.69% | 12.30% | 10.43% | -26.97% | -54.48% | -69.49% | -13.26% | $2.54B |
uniQure N.V.QURE | 14.3% | -1.06% | 7.49% | 24.12% | 10.86% | 102.13% | 209.47% | 355.46% | 681.42% | 72.50% | 208.09% | $3.36B |
| Theme return | — | 1.00% | 3.96% | 7.54% | 11.64% | 37.28% | 35.48% | 55.23% | 21.52% | 6.95% | 57.82% | — |
| Average | 14.3% | 1.00% | 3.96% | 11.65% | 11.75% | 30.49% | 39.79% | 71.37% | 153.72% | 55.57% | 57.05% | $3.96B |
| Median | 14.3% | 2.01% | 5.97% | 18.52% | 10.86% | 28.26% | 12.11% | 73.63% | 0.00% | 0.00% | 22.05% | $2.54B |
| Std Dev | 0.0% | 1.95% | 4.28% | 10.57% | 9.67% | 34.88% | 70.22% | 128.65% | 286.91% | 196.22% | 77.20% | $3.08B |
| Min | 14.3% | -2.24% | -4.19% | -3.98% | 0.00% | -12.69% | -6.82% | -69.92% | -86.63% | -91.88% | -13.26% | $1.06B |
| Max | 14.3% | 3.22% | 8.51% | 24.12% | 26.45% | 102.13% | 209.47% | 355.46% | 681.42% | 515.49% | 208.09% | $10.22B |
| % Positive Tickers | 57.14% | 71.43% | 71.43% | 85.71% | 71.43% | 71.43% | 57.14% | 42.86% | 42.86% | 57.14% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
Rare Diseases '25: Gene Therapy & Genetic Med tracks 7 publicly listed stocks in this theme: KRYS, NTLA, QURE, RARE, SLNO, SRPT, SRRK. See the constituent table for details.